Skin carcinomas are the most common form of cancer in the United States, with the estimated incidence for melanoma to be approximately 50,000 and non-melanoma skin cancers (NMSC) to be 3.5 million. 1,2 Across various industrialized countries, skin cancer leads to significant years of potential life lost and high indirect costs associated with premature mortality and morbidity. 1 One of the major risk factors for skin carcinogenesis is chronic cutaneous inflammation, along with viral infection, ultraviolet radiation (UV) and other inflammation-inducing